Hepatocellular and Prostate Carcinoma
The idea is to investigate the expression of a protein known as GP73 or GOLM1 in patients with hepatocellular carcinoma or prostate cancer in Saudi population.This protein could be sued as a biomarker in serum or in urine, which can be very cost-effective and have almost accurate results. Can you help me to wright the introduction, objective, and literature review. I am attaching some articles you can add more.
I worked with you before and I want you to add more information.